These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 24481770)
21. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect. Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989 [TBL] [Abstract][Full Text] [Related]
22. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls. Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519 [TBL] [Abstract][Full Text] [Related]
23. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
24. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery]. Yasim A; Aşik R; Atahan E Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701 [TBL] [Abstract][Full Text] [Related]
25. Aprotinin reduces the need for blood products during liver transplantation. Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269 [TBL] [Abstract][Full Text] [Related]
26. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626 [TBL] [Abstract][Full Text] [Related]
27. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
28. Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival. Massicotte L; Denault AY; Beaulieu D; Thibeault L; Hevesi Z; Roy A Transplantation; 2011 Jun; 91(11):1273-8. PubMed ID: 21617589 [TBL] [Abstract][Full Text] [Related]
29. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Riddell RE; Buth KJ; Sullivan JA Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043 [TBL] [Abstract][Full Text] [Related]
31. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013 [TBL] [Abstract][Full Text] [Related]
32. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass. Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892 [TBL] [Abstract][Full Text] [Related]
33. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
34. The effect of aprotinin on transfusion requirements in pediatric orthotopic liver transplantation. Rentoul TM; Harrison VL; Shun A Pediatr Transplant; 2003 Apr; 7(2):142-8. PubMed ID: 12654056 [TBL] [Abstract][Full Text] [Related]
35. Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin. Liu CM; Chen J; Wang XH World J Gastroenterol; 2008 Mar; 14(9):1425-9. PubMed ID: 18322960 [TBL] [Abstract][Full Text] [Related]
36. Increased perioperative mortality following aprotinin withdrawal: a real-world analysis of blood management strategies in adult cardiac surgery. Walkden GJ; Verheyden V; Goudie R; Murphy GJ Intensive Care Med; 2013 Oct; 39(10):1808-17. PubMed ID: 23863975 [TBL] [Abstract][Full Text] [Related]
37. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin]. Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511 [TBL] [Abstract][Full Text] [Related]
38. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery. Lindvall G; Sartipy U; Ivert T; van der Linden J Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391 [TBL] [Abstract][Full Text] [Related]
39. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Warnaar N; Mallett SV; de Boer MT; Rolando N; Burroughs AK; Nijsten MW; Slooff MJ; Rolles K; Porte RJ Am J Transplant; 2007 Oct; 7(10):2378-87. PubMed ID: 17711552 [TBL] [Abstract][Full Text] [Related]
40. The effects of aprotinin on blood product transfusion associated with thoracic aortic surgery requiring deep hypothermic circulatory arrest. Seigne PW; Shorten GD; Johnson RG; Comunale ME J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):676-81. PubMed ID: 11139108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]